The Plot Thickens!, page-4

I agree with not selling off the Unifill platform.
In fact I don't want any product line sold off. I would much rather a cornerstone investor (read Sanofi) come in and buy 10% of the company on market and then then have another 10% issued to them.
Or have them earn the other 10% by funding Customer programs and Capex to a nominated amount. (let's face it, if whoever it is wants a cornerstone investment position in this company we don't have to give it to them, there's nothing wrong with making them pay a decent premium for it-otherwise they can pick it up on market like everyone else has to)

I've held UNS for long enough now to understand its value. I know there's others out there with different opinions then me and that's fine.
I'm quite happy to sit and wait with the knowledge that AS and the team have been building this company up to this point. And I know whatever happens he won't be giving it away.